Intraoperative ketamine in total knee arthroplasty does not decrease pain and narcotic consumption: A prospective randomized controlled trial
Journal of Arthroplasty Apr 18, 2019
Tan TL, et al. - To ascertain the efficiency of sub-anesthetic dosing of ketamine during total knee arthroplasty (TKA) on postoperative pain and narcotic consumption, researchers assessed 91 cases in this prospective, randomized, double-blinded clinical trial. Subjects were randomly given intraoperative ketamine infusion at a rate of 6mcg/kg/min for 75 minutes or a saline placebo. No difference was recorded in average pain between ketamine vs placebo at all time points except for at postoperative days 1 (45 vs 56) and 4 (39 vs 49). Only at postoperative day 4, subjects were given ketamine for least pain experienced stated a decrease in pain. They overall did not find a clinically significant improvement in pain and narcotic consumption with intraoperative ketamine administration following TKA.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries